ENGINEER ADIL sold $2.0M of AEHR

ENGINEER ADIL (Chief Operating Officer) sold 15,000 shares of AEHR TEST SYSTEMS (AEHR) at an average of $131.02 ($130.95–$131.10, $1.97M total) across 2 trades on 2026-08-12.

Original reporting
SEC EDGAR · ENGINEER ADIL
Published Aug 13, 2026, 9:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 13, 2026, 10:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AEHR
Neutral
medium confidence
Mentioned
$AEHR
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AEHRNeutralLow
01

Why it matters

Traders may monitor insider activity as a sentiment input, but this disclosure alone does not provide new information about AEHR’s revenue, margins, product pipeline, or guidance.

02

Market read

A newly filed insider sale at AEHR at about $131/share may cause brief sentiment noise, but it is not a fundamental catalyst.

03

What to watch

Insider sales can be driven by diversification, taxes, or personal liquidity needs; the filing does not state intent or whether other holdings/compensation offset the sale.

Relevance 6/10Novelty 4/10Timing: filed after-hours on 2026-08-13, covering trades dated 2026-08-12

Background

The article is a SEC Form 4 insider transaction disclosure for AEHR, filed by its COO.

Company-level read

Ticker impact

$AEHRNeutralMedium confidence
Context

AEHR COO ENGINEER ADIL sold about 15,000 shares in open-market transactions at roughly $131/share, per a newly filed Form 4.

Expected impact

Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment around insider selling.

Evidence & confidence

The filing discloses the sale size, price range, and that it was not under a pre-arranged 10b5-1 plan, but it provides no new AEHR-specific business or guidance information.

Market effects

Minimal. Insider selling at a single small-cap does not materially reset sector expectations without accompanying fundamentals.

None indicated.

None indicated.

Counterpoint

The absence of a 10b5-1 plan could be interpreted as a stronger signal than typical routine sales, potentially increasing near-term downside risk if traders treat it as confidence erosion.

Key entities

  • AEHR

    AEHR Test Systems, the company whose insider transaction was reported.

  • ENGINEER ADIL

    Chief Operating Officer who sold shares via open-market transactions.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AEHRHighAI 9/10

Aehr Test Systems (AEHR) (Q1 2027) Earnings Call Highlights: Record Revenue, Raised

Aehr Test Systems (AEHR) reported record Q1 2027 revenue of $33M and raised annual guidance to $150M. CEO Gayn Erickson highlighted a potential large burn-in opportunity, estimating $35M-$70M in revenue per million units shipped. The company expects sequential growth in remaining quarters, with Q4 potentially the highest. Management confirmed they are not supply-constrained and can ship more than guided. Silicon carbide revenue was about $10M in fiscal 2026, with expectations for growth in 2027.

$AEHRHighAI 9/10

AEHR Stock Surges After Massive AI-Driven Earnings Beat

Aehr Test Systems (AEHR) stock rose 26.6% after reporting Q1 FY27 revenue of $33M, up 300% year-over-year and 75% quarter-over-quarter. Adjusted EPS was $0.28, beating estimates. The company raised FY27 revenue guidance to $150M, citing strong demand for AI and power semiconductor testing.

$AEHRHighAI 9/10

Aehr Stock Jumps 16% After Bookings Hit $46.7 Million

Aehr Test Systems (AEHR) shares rose 16.38% premarket after its Q1 revenue tripled to $33.0M, beating estimates. The company raised its full-year outlook to $150M, citing strong bookings and backlog growth. CEO Gayn Erickson highlighted a major AI customer opportunity. According to GuruFocus, there are 6 warning signs with AEHR.

$AEHRHighAI 8/10

Why is Aehr Test Systems stock surging today?

Aehr Test Systems (AEHR) stock surged 18.8% in pre-market trading after reporting record Q1 2027 revenue of $33.0M, up 200% YoY, and raising full-year revenue outlook to $150M. Non-GAAP net income was $9.4M, or $0.28 per share, exceeding analyst estimates. The company cited strong demand for AI semiconductor test solutions and a book-to-bill ratio of 1.4.

$AEHRMed

Aehr stock jumps on beat and raise amid AI demand

Aehr Test Systems (AEHR) shares rose 15% after reporting Q1 revenue of $33M, up 200% YoY, and raising its FY2027 outlook to $150M. The company cited strong demand for its semiconductor testing systems used in AI chips. CEO Gayn Erickson noted a conservative approach to the revised target. Bookings were $46.7M with a book-to-bill ratio of 1.4.